EQH Q3 Preview: Corebridge Deal Dominates as Print Approaches

Equitable Holdings reports Q3 results on November 2, but the quarterly figures are almost secondary to the larger story reshaping the shares: the agreed takeover of Corebridge Financial, which has set off a wave of index rebalance expectations across multiple benchmarks.

ORTEX forecasts an 84% probability that the Corebridge acquisition triggers a share-count increase in the Russell 1000 and Russell 3000, with an 80% chance of similar treatment in the S&P MidCap 400 and S&P TMI. The MSCI World Small index carries a 65% probability, with an estimated $666 million of index-tracker buying required if that rebalance goes through. All dates are estimated, with announcements expected in late December and an effective date of December 31. These are forecasts, not confirmed changes, and the index providers have not yet made any announcement.

Positioning into the print is relaxed rather than charged. The put/call ratio at 0.23 is barely above its 20-day average of 0.22, less than half a standard deviation from the norm, and nowhere near its 52-week high of 2.71. Short interest is just under 2% of the free float, a level that requires little further elaboration: it fell 6.5% in a single session on October 29 and is now running about 4% below where it was a week ago. The borrow market reflects the same ease: 270 million shares are available against fewer than 6 million shorted, and the cost to borrow at 0.61% is low even after creeping up 15% on the week.

The analyst community has been consistently moving targets higher. Wells Fargo lifted its target to $65 in mid-October while keeping its Overweight rating. Barclays raised its target more aggressively, to $61 from $52, around the same time. The Street mean target is $64, roughly 19% above the current price of $53.85. The stock is up 2.1% over the past week, modestly ahead of its closest peers: CRBG is down 0.8% over the same period, while JXN is up 2.0% and APO has gained 3.2%. The P/E multiple has drifted up about half a point over the past 30 days to just above 6.3x, a modest re-rating that still leaves valuation well below the Street's implied target.

The November 2 print will test whether the underlying business, annuities, asset management and life insurance, is generating the earnings trajectory that justifies both the analyst consensus and the index inflow story building around the Corebridge transaction.